RankingsPricing
  1. JP-listed companies
  2. TAKARA BIO INC.
  3. Financials
  4. Inventories

TAKARA BIO INC.JP:4974

Market cap
¥93.2B
P/E ratio
-10.4x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndInventories (Million JPY)YoY (%)
Mar 31, 20256,794+0.15%
Mar 31, 20246,784+8.58%
Mar 31, 20236,248-67.06%
Mar 31, 202218,966+281.92%
Mar 31, 20214,966+10.09%
Mar 31, 20204,511-0.27%
Mar 31, 20194,523+0.87%
Mar 31, 20184,484+11.21%
Mar 31, 20174,032+5.49%
Mar 31, 20163,822+7.36%
Mar 31, 20153,560

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)